Skip to main content

Table 2 Socio-demographic and clinical characteristics

From: Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study

 

Group 1

Group 2

Total

p value

Number of patients, %

N = 588 (52.5%)

N = 532 (47.5%)

N = 1,120 (100%)

Socio-demographic characteristics

    

Mean age, years

47.3 (12.2)

46.5 (14.8)

46.8 (13.8)

0.351

Ranges: 18–44 years

40.0%

47.9%

44.6%

 

    45-64 years

57.0%

43.2%

48.8%

 

    65-74 years

2.8%

8.6%

6.3%

 

    ≥75 years

0.2%

0.3%

0.3%

<0.001

Gender, male

67.7%

52.0%

58.4%

<0.001

Occupational status, retired

10.4%

10.8%

10.7%

0.662

Overall comorbidity

    

Mean number of comorbidities

8.5 (4.7)

7.0 (4.1)

7.6 (4.4)

<0.001

Mean Charlson Index

0.5 (0.8)

0.4 (0.7)

0.5 (0.8)

0.130

Mean RUBs

3.1 (0.6)

3.0 (0.7)

3.0 (0.7)

0.098

 1 (very low)

1.2%

3.4%

2.5%

 

 2 (low)

11.4%

11.8%

11.7%

 

 3 (moderate)

69.6%

68.9%

69.2%

 

 4 (high)

15.2%

13.6%

14.3%

 

 5 (very high)

2.6%

2.3%

2.4%

0.218

Comorbid diagnoses

    

Arterial hypertension

44.1%

34.1%

38.2%

0.001

Diabetes mellitus

22.5%

17.1%

19.3%

0.024

Dyslipidemia

54.1%

44.9%

48.7%

0.002

Obesity

28.4%

18.7%

22.7%

0.001

Vascular events

19.0%

16.3%

17.4%

0.245

Organ failure

17.9%

15.3%

16.3%

0.239

Bronchial asthma

8.7%

5.6%

6.9%

0.041

COPD

5.9%

3.6%

4.6%

0.073

Neuropathies

3.9%

3.0%

3.4%

0.409

Risk factors

    

Active smoking

28.4%

30.5%

29.6%

0.443

Alcoholism

7.2%

5.4%

6.2%

0.227

Mean time since schizophrenia onset, years

19.9

18.2

18.9

0.093

  1. Group 1: presence of one or more negative symptoms; Group 2: absence of negative symptoms; RUBs: resource utilisation bands; COPD: chronic obstructive pulmonary disease. Values are given as percentage or mean (standard deviation).